One should also consider the altered postnatal adaptation of ELGANs, where lung fluid clearance of the airways by aquaporin-4 channels (AQP4) is less effective (18), and the additional impact of the respiratory distress syndrome (RDS), which is the reason these infants should be treated via LISA/MIST. Here, AQP4 is linked to newborn respiratory distress syndrome.